Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2022 | Seed | $4.06M | 1 | — | — | Detail |
Sep 1, 2021 | Seed | $1.48M | 1 | — | — | Detail |
Sep 21, 2020 | Grant | $1M | 1 | National Science Foundation | — | Detail |
Jun 24, 2019 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Gaingels | — | Seed |
Quaker Capital Investments, LLC | — | Seed |